missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human C9orf156 (aa 328-441) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (79%), Rat (79%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-54368 (PA5-54368. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
S-adenosyl-L-methionine-dependent methyltransferase responsible for the addition of the methyl group in the formation of N6-methyl-N6-threonylcarbamoyladenosine at position 37 (m(6)t(6)A37) of the tRNA anticodon loop of tRNA(Ser)(GCU) (PubMed:25063302). The methyl group of m(6)t(6)A37 may improve the efficiency of the tRNA decoding ability. May bind to tRNA. [UniProt]
Specifications
Specifications
| Accession Number | Q9BU70 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 51531 |
| Name | Human C9orf156 (aa 328-441) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 5830415F09Rik; AV014846; C9orf156; HSPC219; likely ortholog of H. sapiens chromosome 9 open reading frame 156 (C9orf156); NAP1; Nef (lentivirus myristoylated factor) associated protein 1; Nef associated protein 1; nef-associated protein 1; RGD1305420; RIKEN cDNA 5830415F09 gene; similar to Nef associated protein 1; thioesterase NAP1; TRMO; tRNA (adenine(37)-N6)-methyltransferase; tRNA methyltransferase O |
| Common Name | C9orf156 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction